Huang X
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023; 52(6):744-750.
PMID: 37807629
PMC: 10764184.
DOI: 10.3724/zdxbyxb-2023-0378.
Francini-Pesenti F, Gugelmo G, Lenzini L, Vitturi N
Nutrients. 2020; 12(11).
PMID: 33138136
PMC: 7693747.
DOI: 10.3390/nu12113331.
Kido J, Matsumoto S, Mitsubuchi H, Endo F, Nakamura K
Metab Brain Dis. 2018; 33(5):1517-1523.
PMID: 29948653
DOI: 10.1007/s11011-018-0259-6.
Kido J, Kawasaki T, Mitsubuchi H, Kamohara H, Ohba T, Matsumoto S
World J Hepatol. 2017; 9(6):343-348.
PMID: 28293384
PMC: 5332424.
DOI: 10.4254/wjh.v9.i6.343.
Hook D, Diaz G, Lee B, Bartley J, Longo N, Berquist W
Mol Genet Metab Rep. 2016; 6:34-40.
PMID: 27014577
PMC: 4789342.
DOI: 10.1016/j.ymgmr.2015.11.002.
Clinical manifestations and growth of patients with urea cycle disorders in Japan.
Nakamura K, Kido J, Matsumoto S, Mitsubuchi H, Endo F
J Hum Genet. 2016; 61(7):613-6.
PMID: 26935171
DOI: 10.1038/jhg.2016.17.
On the Creation, Utility and Sustaining of Rare Diseases Research Networks: Lessons learned from the Urea Cycle Disorders Consortium, the Japanese Urea Cycle Disorders Consortium and the European Registry and Network for Intoxication Type Metabolic....
Summar M, Endo F, Kolker S
Mol Genet Metab. 2014; 113(1-2):105-8.
PMID: 25261246
PMC: 4868037.
DOI: 10.1016/j.ymgme.2014.09.002.
Liver engraftment and repopulation by in vitro expanded adult derived human liver stem cells in a child with ornithine carbamoyltransferase deficiency.
Sokal E, Stephenne X, Ottolenghi C, Jazouli N, Clapuyt P, Lacaille F
JIMD Rep. 2013; 13:65-72.
PMID: 24142276
PMC: 4110332.
DOI: 10.1007/8904_2013_257.
Amino Acid Profiles in Patients with Urea Cycle Disorders at Admission to Hospital due to Metabolic Decompensation.
Rodney S, Boneh A
JIMD Rep. 2013; 9:97-104.
PMID: 23430554
PMC: 3565665.
DOI: 10.1007/8904_2012_186.
Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ.
Mew N, Krivitzky L, McCarter R, Batshaw M, Tuchman M
J Pediatr. 2012; 162(2):324-9.e1.
PMID: 22901741
PMC: 4440324.
DOI: 10.1016/j.jpeds.2012.06.065.
Suggested guidelines for the diagnosis and management of urea cycle disorders.
Haberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M
Orphanet J Rare Dis. 2012; 7:32.
PMID: 22642880
PMC: 3488504.
DOI: 10.1186/1750-1172-7-32.
Long-term outcome and intervention of urea cycle disorders in Japan.
Kido J, Nakamura K, Mitsubuchi H, Ohura T, Takayanagi M, Matsuo M
J Inherit Metab Dis. 2011; 35(5):777-85.
PMID: 22167275
DOI: 10.1007/s10545-011-9427-0.
Clinical practice: the management of hyperammonemia.
Haberle J
Eur J Pediatr. 2010; 170(1):21-34.
PMID: 21165747
DOI: 10.1007/s00431-010-1369-2.
Nutritional management of patients with urea cycle disorders.
Singh R
J Inherit Metab Dis. 2007; 30(6):880-7.
PMID: 18034368
DOI: 10.1007/s10545-007-0718-4.
Contrasting features of urea cycle disorders in human patients and knockout mouse models.
Deignan J, Cederbaum S, Grody W
Mol Genet Metab. 2007; 93(1):7-14.
PMID: 17933574
PMC: 2692509.
DOI: 10.1016/j.ymgme.2007.08.123.
Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency.
Nagasaka H, Yorifuji T, Murayama K, Kubota M, Kurokawa K, Murakami T
Eur J Pediatr. 2006; 165(9):618-24.
PMID: 16703326
DOI: 10.1007/s00431-006-0143-y.
Urea Cycle Disorders.
Kleppe S, Mian A, Lee B
Curr Treat Options Neurol. 2003; 5(4):309-319.
PMID: 12791198
DOI: 10.1007/s11940-003-0037-5.